ArticleThe Journal of dermatology2025

Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective study.

Ken Horisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.